Literature DB >> 35544245

A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review.

Raghuraman M Sethuraman1, Satyen Parida2, Adinarayanan Sethuramachandran2, Priyanka Selvam3.   

Abstract

Hemoglobin A1c (A1C) or glycated hemoglobin reflects the levels of blood glucose during the previous 8-12 weeks duration. It also helps us to diagnose diabetes in some cases, during the preoperative screening, who were initially missed out. Although the number of patients with diabetes undergoing various surgeries has increased many times, the role of A1C as a predictor for the complications during the perioperative phase remains intriguing. This could be due to various factors such as lack of best shreds of evidence, various cut-off levels of target A1C, variations of the patient population, presence of other comorbid conditions, and so on. This narrative review article presents the role of A1C as a reflector of perioperative adverse events in various surgeries and discusses the controversies surrounding it. We searched "PubMed Central" database with search criteria of "hemoglobin A1c, glycated hemoglobin, and perioperative complications" with publication date from January 01, 2010, to January 31, 2020, and found a total of 214 articles. We included only the relevant articles to our topic and added a few more articles that we found as "secondary references" from those articles to suit the structured headings of our narrative review and made it a total of fifty. To our knowledge, the majority of the studies published on this topic are of the "Retrospective analysis" type of study, besides no narrative review article available to date in the literature. We suggest that assessment of A1C levels preoperatively can be used as a routine practice for major procedures in patients with diabetes and for patients who have persistent high glucose values during preoperative screening regardless of whether a diagnosis of diabetes is established or not. We found that a cut-off of 8% is acceptable for the majority of the surgical procedures. However, it is better to have a cut-off of 7% or lower for procedures such as spine and joint replacement surgeries, cardiac surgeries, and so on. Further prospective studies involving a large population preferably with a multicenter design would provide us more clarity on this topic.

Entities:  

Year:  2022        PMID: 35544245      PMCID: PMC9361335          DOI: 10.5152/TJAR.2021.854

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  49 in total

1.  Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.

Authors:  Aruna D Pradhan; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Am J Med       Date:  2007-08       Impact factor: 4.965

2.  Preoperative hemoglobin A1c and postoperative glucose control in outcomes after gastric bypass for obesity.

Authors:  Mark Perna; Joseph Romagnuolo; Kathyrn Morgan; T Karl Byrne; Megan Baker
Journal:  Surg Obes Relat Dis       Date:  2011-08-10       Impact factor: 4.734

3.  The association of preoperative haemoglobin A1c with 30-day postoperative surgical site infection following non-cardiac surgery.

Authors:  Rodney A Gabriel; Diana J Hylton; Brittany N Burton; Ulrich H Schmidt; Ruth S Waterman
Journal:  J Perioper Pract       Date:  2019-11-07

4.  Glycemic control and infections in patients with diabetes undergoing noncardiac surgery.

Authors:  Joseph T King; Joseph L Goulet; Melissa F Perkal; Ronnie A Rosenthal
Journal:  Ann Surg       Date:  2011-01       Impact factor: 12.969

5.  The Association Between Preoperative Hemoglobin A1C and Postoperative Glycemic Variability on 30-Day Major Adverse Outcomes Following Isolated Cardiac Valvular Surgery.

Authors:  Amit Bardia; Kamal Khabbaz; Ariel Mueller; Priyam Mathur; Victor Novack; Daniel Talmor; Balachundhar Subramaniam
Journal:  Anesth Analg       Date:  2017-01       Impact factor: 5.108

6.  The relationship between glycosylated hemoglobin and perioperative glucose control in patients with diabetes.

Authors:  Vivek K Moitra; Jason Greenberg; Srikesh Arunajadai; BobbieJean Sweitzer
Journal:  Can J Anaesth       Date:  2010-02-03       Impact factor: 5.063

7.  Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events.

Authors:  Harold L Lazar; Stuart R Chipkin; Carmel A Fitzgerald; Yusheng Bao; Howard Cabral; Carl S Apstein
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

8.  The prevalence of elevated hemoglobin A1c in patients undergoing coronary artery bypass surgery.

Authors:  Milo Engoren; Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir Shah
Journal:  J Cardiothorac Surg       Date:  2008-11-24       Impact factor: 1.637

Review 9.  Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty?: A systematic review and meta-analysis.

Authors:  Liqing Yang; Yuefeng Sun; Ge Li; Jiulong Liu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  Preoperative Diabetes Optimization Program.

Authors:  Carlos E Mendez; Njeri Wainaina; Rebekah J Walker; William Montagne; Austin Livingston; Barbara Slawski; Leonard E Egede
Journal:  Clin Diabetes       Date:  2018-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.